FABHALTA

Identification of Fabhalta

No description

Google image searchProduct monograph

Active ingredient

iptacopan (iptacopan hydrochloride), 200 MG

DIN: 02554313

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 28-MAR-2025

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AJ — Complement inhibitors (ATC, ATC/DDD)
• L04AJ08 — IPTACOPAN (ATC/DDD)

External Links for Fabhalta

Search on Google

• Fabhalta side effects
• Fabhalta dosage
• iptacopan side effects
• iptacopan dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find fabhalta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.